MoneyWorks4Me

Sandu Pharmaceutical - Quaterly Results

13 Feb 2025 Evaluate
A fair growth of 5.42% in the revenue at Rs. 183.73 millions was reported in the December 2024 quarter as compared to Rs. 174.29 millions during year-ago period.The Net Profit of the company vaulted to 169.42% to Rs. 5.55  millions from Rs. 2.06 millions in the previous quarter.The company reported a good operating profit of 10.15 millions compared to 5.37 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 183.73 174.29 5.42 531.23 516.93 2.77 672.81 653.49 2.96
Other Income 0.25 0.27 -7.41 0.99 1.15 -13.91 4.21 3.27 28.75
PBIDT 10.15 5.37 89.01 24.12 18.06 33.55 27.18 28.16 -3.48
Interest 0.27 0.18 50.00 0.76 0.56 35.71 0.63 0.80 -21.25
PBDT 9.88 5.19 90.37 23.36 17.50 33.49 26.55 27.36 -2.96
Depreciation 1.90 1.42 33.80 5.23 3.97 31.74 5.83 5.17 12.77
PBT 7.98 3.77 111.67 18.13 13.53 34.00 20.72 22.19 -6.62
TAX 2.43 1.71 42.11 5.91 4.86 21.60 6.12 6.96 -12.07
Deferred Tax 0.14 0.64 -78.13 0.77 1.10 -30.00 0.25 0.34 -26.47
PAT 5.55 2.06 169.42 12.22 8.67 40.95 14.60 15.23 -4.14
Equity 96.61 96.61 0.00 96.61 96.61 0.00 96.61 96.61 0.00
PBIDTM(%) 5.52 3.08 79.30 4.54 3.49 29.96 4.04 4.31 -6.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..